# Dana-Farber Cancer Institute

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/dana-farber-cancer-institute/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 70.7 |
| Citations | 27,485,770 |
| City | Boston |
| Country | US |
| Description | Dana-Farber Cancer Institute is a research organisation in Boston, US. OpenAlex records 89,208 works and 27,485,770 citations for it. 14,518 researchers list it as their most recent affiliation. |
| Homepage | http://www.dana-farber.org/ |
| OpenAlex ID | https://openalex.org/I4210117453 |
| Researchers | 14,518 |
| ROR ID | https://ror.org/02jzgtq86 |
| Type | facility |
| Works | 89,208 |

## University collaborators

Showing 10 of 20.

- [Harvard University](https://scholariq.org/institutions/harvard-university/)
- [Broad Institute](https://scholariq.org/institutions/broad-institute/)
- [Massachusetts Institute of Technology](https://scholariq.org/institutions/massachusetts-institute-of-technology/)
- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)
- [Massachusetts General Hospital](https://scholariq.org/institutions/massachusetts-general-hospital/)
- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)
- [Howard Hughes Medical Institute](https://scholariq.org/institutions/howard-hughes-medical-institute/)
- [University of California, San Francisco](https://scholariq.org/institutions/university-of-california-san-francisco/)
- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)
- [Whitehead Institute for Biomedical Research](https://scholariq.org/institutions/whitehead-institute-for-biomedical-research/)

## University papers

Showing 12 of 174.

- [Bioconductor: open software development for computational biology and bioinformatics](https://scholariq.org/papers/bioconductor-open-software-development-for-computational-biology-and/)
- [<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy](https://scholariq.org/papers/i-egfr-i-mutations-in-lung-cancer-correlation-with-clinical-response-to/)
- [Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer](https://scholariq.org/papers/paclitaxel-carboplatin-alone-or-with-bevacizumab-for-non-small-cell-lung-cancer/)
- [A Draft Sequence of the Neandertal Genome](https://scholariq.org/papers/a-draft-sequence-of-the-neandertal-genome/)
- [<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling](https://scholariq.org/papers/i-met-i-amplification-leads-to-gefitinib-resistance-in-lung-cancer-by-activating/)
- [<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib](https://scholariq.org/papers/i-egfr-i-mutation-and-resistance-of-non-small-cell-lung-cancer-to-gefitinib/)
- [Integrative Genomic Profiling of Human Prostate Cancer](https://scholariq.org/papers/integrative-genomic-profiling-of-human-prostate-cancer/)
- [Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial](https://scholariq.org/papers/atezolizumab-in-patients-with-locally-advanced-and-metastatic-urothelial/)
- [Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma](https://scholariq.org/papers/pembrolizumab-as-second-line-therapy-for-advanced-urothelial-carcinoma/)
- [The Mutational Landscape of Head and Neck Squamous Cell Carcinoma](https://scholariq.org/papers/the-mutational-landscape-of-head-and-neck-squamous-cell-carcinoma/)
- [Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study](https://scholariq.org/papers/prognostic-factors-for-overall-survival-in-patients-with-metastatic-renal-cell/)
- [Evolution of genes and genomes on the Drosophila phylogeny](https://scholariq.org/papers/evolution-of-genes-and-genomes-on-the-drosophila-phylogeny/)

## University researchers

- [Henry W. Long](https://scholariq.org/researchers/henry-w-long/)
- [Biagio Ricciuti](https://scholariq.org/researchers/biagio-ricciuti/)
- [Christine E. Ryan](https://scholariq.org/researchers/christine-e-ryan/)
- [Francesco Facchinetti](https://scholariq.org/researchers/francesco-facchinetti/)
- [Nora Feeney](https://scholariq.org/researchers/nora-feeney/)

## University top topics

Showing 8 of 25.

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.